- The medicine could help keep people from needing breathing machines
- Ibuprofen could halt the onset of lung damage
- The drug trial is set to conclude in May 2021
Despite getting a bad rap early in the pandemic when the French government and the World Health Organization advised against taking it, ibuprofen might actually be helpful for facilitating recovery in coronavirus patients and keeping them off ventilators, according to the BBC.
The anti-inflammatory properties of ibuprofen are being tested in a trial of coronavirus patients by U.K. researchers, who are using a version of the drug that’s commonly used to treat patients with arthritis. Lipid ibuprofen softgels are being administered to patients within the trial, which is currently seeking more participants over the age of 18.
This trial is expected to conclude in May 2021. By its end, experts hope to determine how much benefit ibuprofen can offer to mitigate the respiratory issues that come with severe coronavirus cases. In particular, it could prevent the onset of acute respiratory distress syndrome. ARDS causes lung damage in coronavirus patients, as their lungs begin to fill with fluid and provide less air to the bloodstream. This syndrome also causes failure in other organs due to a lack of oxygen.
Will taking ibuprofen keep me from getting COVID-19?
There are currently no drug or therapeutic methods of preventing contraction of COVID-19 aside from proper hand washing and social distancing practices, as recommended by the CDC. Taking ibuprofen in excess can cause a litany of side effects, including sour stomach, diarrhea, nausea, and abdominal pain. Experts advise patients who have been prescribed ibuprofen to alleviate symptoms of coronavirus to continue taking it as directed.